Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Vitesse Energy
VTS
$665M
| $854K | ﹤0.01% |
39,006
+30,116
| +339% | +$695K |
|
3477
Abeona Therapeutics
ABEO
$413M
| $850K | ﹤0.01% |
169,732
-201,544
| -54% | -$887K |
|
3478
Castle Biosciences
CSTL
$979M
| $850K | ﹤0.01% |
39,380
+30,398
| +338% | +$535K |
|
|
CTEV
3479
Claritev Corp
CTEV
$556M
| $850K | ﹤0.01% |
14,752
+11,567
| +363% | +$702K |
|
|
GOOS
3480
Canada Goose Holdings
GOOS
$856M
| $848K | ﹤0.01% |
71,596
-600,846
| -89% | -$7.11M |
|
3481
JFrog
FROG
$10.8B
| $847K | ﹤0.01% |
24,483
+11,310
| +86% | +$306K |
|
3482
Stagwell
STGW
$2.24B
| $845K | ﹤0.01% |
127,413
+89,449
| +236% | +$446K |
|
3483
Corsair Gaming
CRSR
$1.55B
| $844K | ﹤0.01% |
59,838
+39,869
| +200% | +$534K |
|
|
ACRE
3484
Ares Commercial Real Estate
ACRE
$270M
| $842K | ﹤0.01% |
81,275
+62,963
| +344% | +$620K |
|
3485
Annexon
ANNX
$886M
| $841K | ﹤0.01% |
185,331
+149,600
| +419% | +$370K |
|
3486
Donegal Group Class A
DGICA
$714M
| $840K | ﹤0.01% |
60,033
+18,954
| +46% | +$270K |
|
3487
Karyopharm Therapeutics
KPTI
$48M
| $839K | ﹤0.01% |
64,671
-12,149
| -16% | -$164K |
|
|
SPLK
3488
CALL
DELISTED
Splunk Inc
SPLK
| $838K | ﹤0.01% |
5,500
-255,300
| -98% | -$38.1M |
|
3489
World Acceptance Corp
WRLD
$873M
| $837K | ﹤0.01% |
6,413
+4,327
| +207% | +$507K |
|
|
MRO
3490
PUT
DELISTED
Marathon Oil Corporation
MRO
| $836K | ﹤0.01% |
+34,600
| New | +$891K |
|
|
GOOD
3491
Gladstone Commercial Corp
GOOD
$627M
| $834K | ﹤0.01% |
62,995
+48,832
| +345% | +$611K |
|
|
DDL
3492
Dingdong
DDL
$503M
| $833K | ﹤0.01% |
555,613
| – | – |
|
|
MCBC
3493
DELISTED
Macatawa Bank Corp
MCBC
| $833K | ﹤0.01% |
73,858
+33,099
| +81% | +$324K |
|
3494
HUTCHMED
HCM
$2.17B
| $832K | ﹤0.01% |
45,918
| – | – |
|
3495
Summit Therapeutics
SMMT
$11.1B
| $831K | ﹤0.01% |
318,565
+170,549
| +115% | +$351K |
|
3496
Evolv Technologies
EVLV
$1.1B
| $831K | ﹤0.01% |
176,111
+141,541
| +409% | +$605K |
|
3497
Driven Brands
DRVN
$2.2B
| $830K | ﹤0.01% |
58,238
+18,536
| +47% | +$231K |
|
|
MRNS
3498
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $830K | ﹤0.01% |
76,372
+67,360
| +747% | +$505K |
|
3499
CALL
Leslie's
LESL
$11M
| $827K | ﹤0.01% |
+5,985
| New | +$658K |
|
3500
CEVA Inc
CEVA
$1.08B
| $826K | ﹤0.01% |
36,380
+25,469
| +233% | +$524K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.